Menu
ÚHKT

Impaktované publikace

[81]

Majek, P.; Pecankova, K.; Cermak, J.; Gasova, Z.; Prochazka, B.; Dyr, J.E.

Alpha-2-HS-glycoprotein plasma level decrease correlates with age in patients with myelodysplastic syndromes

[rok vydání 2018, impact factor 2.392 ]

[82]

Čermák, J.; Beličková, M.; Krejčová, H.; Michalová, K.; Žilovcová, S.; Zemanová, Z.; Březinová, J.; Sieglová, Z.

The presence of clonal cell populations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.

[rok vydání 2006, impact factor 2.372]

[83]

Cermak, J.; Kacirkova, P.; Mikulenkova, D.; Michalova, K.

Impact of transfusion dependency on survival in patients with early myelodysplastic syndrome without excess of blasts

[rok vydání 2009, impact factor 2.358]

[84]

Čermák, J.; Michalová, K.; Březinová, J.; Zemanová, Z.

A prognostic impact of separation of refractory cytopenia with multilineage dysplasia and 5q- syndrome from refractory anemia in primary myelodysplastic syndrome

[rok vydání 2006, impact factor 2.333]

[85]

Krejčík, Z.; Beličková, M.; Hruštincová, A.; Kléma, J.; Zemanová, Z.; Michalová, K.; Čermák, J.; Jonášová, A.; Dostálová Merkerová, M.

Aberrant expression of the microRNA cluster in 14q32 is associated with del(5q) myelodysplastic syndrome and lenalidomide treatment

[rok vydání 2015, impact factor 2.333 ]

[86]

Májek, P.; Reicheltová, Z.; Suttnar, J.; Čermák, J.; Dyr, J.E.

Plasma proteome changes associated with refractory cytopenia with multilineage dysplasia

[rok vydání 2011, impact factor 2.328 ]

[87]

Čermák, J.; Vítek, A.; Michalová, K.

Combined stratification of refractory anemia according to both WHO and IPSS criteria has a prognostic impact and improves identification of patients who may benefit from stem cell transplantation

[rok vydání 2006, impact factor 2.244]

[88]

Sieglová, Z.; Žilovcová, S.; Čermák, J.; Říhová, H.; Březinová, D.; Dvořáková, R.; Marková, M.; Maaloufová, J.; Sajdová, J.; Březinová, J.; Zemanová, Z.; Michalová, K.

Dynamics of telomere erosion and its association with genome instability in myelodysplastic syndromes (MSD) and acute myelogenous leukemia arising from MDS : a marker of disease prognosis?

[rok vydání 2006, impact factor 2.244]

[89]

Majek, P.; Riedelova-Reicheltova, Z.; Suttnar, J.; Pecankova, K.; Cermak, J.; Dyr, J.E.

Proteome changes in the plasma of myelodysplastic syndrome patients with refractory anemia with excess blasts subtype 2

[rok vydání 2014, impact factor 2.174 ]

[90]

Pecankova, K.; Majek, P.; Cermak, J.; Dyr, J.E.

Peripheral blood mononuclear cell proteome changes in patients with myelodysplastic syndrome

[rok vydání 2014, impact factor 2.134 ]

[91]

Majek, P.; Pecankova, K.; Cermak, J.; Dyr, J.E.

Plasma protein biomarker candidates for myelodysplastic syndrome subgroups

[rok vydání 2015, impact factor 2.134 ]

[92]

de Swart, L.; Smith, A.; Haase, D.; Fenaux, P.; Symeonidis, A.; Cermak, J.; et al.

Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS

[rok vydání 2018, impact factor 2.066 ]

[93]

Miyazaki, Y.; Tuechler, H.; Sanz, G.; Schanz, J.; Garcia-Manero, G.; Solé, F.; Bennett, J.M.; Bowen, D.; Fenaux, P.; Dreyfus, F.; Kantarjian, H.; Kuendgen, A.; Malcovati, L.; Cazzola, M.; Cermak, J.; et al.

Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: analysis from the International Working Group for Prognosis of MDS

[rok vydání 2018, impact factor 2.066 ]

[94]

aut. Suttnar, Jiří

Solid phase extraction in malondialdehyde analysis

[rok vydání 2006, impact factor 2.017]

[95]

Valka, J.; Vesela, J.; Votavova, H.; Dostalova-Merkerova, M.; Urbanova, Z.; Jonasova, A.; Cermak, J.; Belickova, M.

Genetic variant screening of DNA repair genes in myelodysplastic syndrome identifies a novel mutation in the XRCC2 gene

[rok vydání 2019, impact factor 1.967 ]

[96]

Kracmarova, A.; Cermak, J.; Brdicka, R.; Bruchova, H.

High expression of ERCC1, FLT1, NME4 and PCNA associated with poor prognosis and advanced stages in myelodysplastic syndrome

[rok vydání 2008, impact factor 1.939]

[97]

Smetana, K.; Klamová, H.; Mikulenková, D.; Čermák, J.; Otevřelová, P.; Karban, J.; Trněný, M.

The cell body space occupied by the nucleus during the cell differentiation in human lymphocytic, granulocytic and erythroid cell lineages

[rok vydání 2021, impact factor 1.881 ]

[98]

Májek, P.; Riedelová-Reicheltová, Z.; Suttnar, J.; Pečánková, K.; Čermák, J.; Dyr, J.E.

Plasma proteome changes associated with refractory anemia and refractory anemia with ringed sideroblasts in patients with myelodysplastic syndrome.

[rok vydání 2013, impact factor 1.878 ]

[99]

Cermak, J.; Brabec, V.

Transferrin receptor-ferritin index : a useful parametr in differential diagnosis of iron deficiency and hyperplastic erythropoiesis

[rok vydání 2006, impact factor 1.846]

[100]

aut. Michalová, K.

Double minute chromosomes in a patient with myelodysplastic syndrome transforming into acute myeloid leukemia

[rok vydání 2006, impact factor 1.756]